Women’s Health Products Market Outlook 2017 Sales Revenue, Strategy to 2025

Increasing expenditure on developing a robust healthcare infrastructure in turn has led to rapid growth in health awareness among the populace, augmented by counselling and educational programs by hospitals. Various government and private bodies have also taken up the initiative with regards to women’s health through care program, college women campaign program, and food safety for moms to be. According to International Osteoporosis Foundation (IOF) report, by 2050, 42% of women over 50 years will experience osteoporosis fractures due to lack of calcium and phosphate. Postmenopausal osteoporosis accounts for the largest market share. Due to government initiative to spread awareness about the contraception and fertility in the emerging economies such as India and China to restrict the population growth is expected to boost the women healthcare market in the near future. In developed economies, most women have stopped using contraceptive pill due to side effects such as endometriosis, menorrhagia, dysmenorrhea, premenstrual syndrome, alopecia, and hirsutism has increased the use of IUDs and implants. Increasing awareness about alternative methods will fuel market growth.

Ask for detailed Sample of the Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/552

The global women’s health products market is segmented into different regions: North America, Latin America Asia Pacific, Europe, Middle East and Africa. North America is leading the women’s health products market due to rapidly increasing aging female population, which leads to various health issues such as postmenopausal osteoporosis and endometriosis. Presence of research facilities and labs which helps North America to lead the market. Europe is the second largest emerging region in this market followed by Asia Pacific supported by rapid development in economy and increase in awareness and healthcare facilities.

Some popular products in the market are bresol syrup, evecare capsules, lukol tablets, reosto, and hiowna. Major players in the women’s healthcare products market are Allergan Pharmaceuticals, Pfizer Pharmaceuticals, Bayer Healthcare, Merck & Co., Teva Pharmaceutical industries, Lupin Ltd., Novo Nordisk Pharmaceutical, GlaxoSmithKline plc., AstraZeneca, Novartis AG, and Sanofi.

Women health products provide additional nutrients and minerals to the body to increase immunity for prevention of common health issues. Women’s health is a major concern nowadays, as increasing number of women in the workforce translates to lesser time on maintaining health. This makes their body weak and deficient in nutrition and may lead to health problems and diseases such as osteoporosis, vitamin deficiency and infertility. Good nutrition plays a major role to look after women’s health, along with mood and energy level. It is also essential to maintain hormonal balance and precise body requirements throughout women’s life. According to World Health Organization (WHO), in 2014, around 13.3% of women over 18 years were in fair or poor health condition. Various government initiatives and programs by non-governmental bodies has led to increasing awareness among the populace about women’s health and in turn creates a highly conducive environment for growth of the women’s healthcare products market.

Access Table of Content (TOC) Of the Report: https://www.coherentmarketinsights.com/ongoing-insight/toc/552

Women’s health products market taxonomy

By Application: Postmenopausal, Osteoporosis, Contraceptives, Infertility, Menopause, Endometriosis, Polycystic Ovary Syndrome,. By Geography: North America, Latin America, Europe, Asia Pacific, Middle East, Africa,.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave,
#3200
Seattle, WA 98154

This release was published on openPR.